Ten big drug companies unite to study major diseases

Ten big pharmaceutical companies are uniting with the National Institutes of Health in a five-year cooperative program to study major diseases. The companies and the NIH will share scientists, samples and research on Alzheimer’s disease, diabetes, rheumatoid arthritis and lupus. Results will be free for anyone to use. Monica Langley reflects on the groundbreaking collaboration.